Selvakumar Elangovan
Selvakumar Elangovan
Associate Professor
Dr. Selvakumar Elangovan was graduated from the University of Madras in 2006 in the field of Biochemistry. Then, he did postdoctoral studies at New York Medical College, USA and Georgia Health Sciences University, Augusta, USA. He has studied the mechanisms of the chemopreventive effects of natural compounds during his postdoctoral studies at New York Medical College. During his tenure at Georgia Health Sciences University, he has extensively studied the molecular signaling mechanisms of breast cancer initiation, progression and metastasis. Dr. Selvakumar is currently studying the molecular mechanisms of breast cancer invasion and metastasis. He is specifically interested in the signaling pathways associated with the estrogen receptor alpha (ERα), estrogen-related receptor alpha (ERRα) and TGFβ. He is also studying the chemopreventive and anticancer mechanisms of natural and plant-derived compounds. Along with research, he is teaching biochemistry, molecular biology and enzymology subjects to Master’s students.
Educational Qualification
PhD
Course Expertise
Research Interests
Administrative Responsibilities
- Examinations in charge for School of Biotechnology
Professional Membership
- Member, American Association for Cancer Research, (AACR), Philadelphia, USA
- Member, The Indian Science Congress Association, Kolkata, India.
Projects & Collaborations
- Role of estrogen-related receptor α (ERRα) on the self-renewal of breast cancer stem cells, and its implications in the chemoresistance; Funding agency: ICMR; Duration: 2020-2023.
- Role of estrogen-related receptor α (ERRα) in epithelial-mesenchymal transition and metastasis of breast cancer Funding agency: SERB, DST; Duration: 2018-2021.
- Effect of lipoic acid on radiation-induced TGFβ signalling in breast cancer cells; Funding agency: BRNS; DAE. Duration: 2016-2019.